IL2RA and neoplasm: However, tumor uptake of 89Zr-labeled IgG2a isotype control Ab was low at 3.6 ± 0.9%ID, which was even lower than tumor 89Zr-CD25 IgG uptake in the presence of excess unlabeled anti-CD25 IgG (Figure 5).